Sphingomyelinase Deficiency Treatment & Management
- Author: Lynne Ierardi-Curto, MD, PhD; Chief Editor: Bruce Buehler, MD more...
At present, no specific treatment is available for patients with any Niemann-Pick disease (NPD) type A, and treatment is symptomatic.
Adult patients with elevated serum cholesterol due to NPD type B should be treated to bring serum cholesterol concentration into the normal range. Liver function should be monitored in patients treated with statins.
Transfusion of blood products may be necessary for acute episodes of bleeding secondary to hypersplenism and thrombocytopenia in NPD type B patients.
Supplemental oxygen may be used for NPD type B patients with symptomatic interstitial lung disease. Bronchopulmonary lavage has had variable results.
Orthotopic liver transplantation in an infant with Niemann-Pick disease (NPD) type A and amniotic cell transplantation in several patients with NPD type B have been attempted with little or no success.
Bone marrow transplantation has been attempted in patients with NPD type B with variable results, including reduction in spleen and liver volumes, increased peripheral blood cell counts, and decreased infiltration of the lungs. It is not considered appropriate for treatment of NPD with neurologic involvement.
Histocompatible hematopoietic stem cell transplantation conducted on a 4-year-old girl with NPD type B was successful in improving sphingomyelinase enzyme levels and improving severe pulmonary disease.
To date, lung transplantation has not been performed in any patient with type B disease who was severely compromised.
Although patients may have massive splenomegaly, splenectomy should be avoided whenever possible. Removal of the spleen is accompanied by deterioration of pulmonary status and increased morbidity since it eliminates an important reservoir for substrate accumulation that leads to acceleration of disease in other organs such as the lung.
Pulmonary infections occur frequently in patients with Niemann-Pick disease (NPD) types A and B.
Patients with type A disease may develop respiratory decompensation, requiring inpatient care for stabilization during severe episodes.
Pediatric patients with NPD type B require frequent meals to promote growth. Many patients have early satiety because of organomegaly. For some patients, supplements with high levels of kilojoules are useful.
In patients with NPD type A, feeding becomes a major difficulty as the disease progresses. Discussion with the family to determine a strategy for providing calories should occur.
Patients with NPD type B disease and splenomegaly should avoid contact sports because of the risk of splenic rupture. Immediate medical attention should be obtained after trauma, owing to the risk of splenic rupture and intracranial bleeding due to hypersplenism.
Evaluation and ongoing care by a trained metabolic geneticist should occur.
Patients with NPD type B should undergo annual pulmonary function testing and evaluation.
Camoletto PG, Vara H, Morando L, et al. Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18. PLoS ONE. 2009. 4(4):e5310. [Medline].
Jenkins RW, Canals D, Hannun YA. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal. 2009 Jun. 21(6):836-46. [Medline].
Ambrosio C, Serra S, Alexandre M, Malcata A. [Arthralgia, bone pain, positive antinuclear antibodies and thrombocytopenia...diagnosis: Niemann-Pick disease]. Acta Reumatol Port. 2009 Jan-Mar. 34(1):102-5. [Medline].
Cho YU, Chae JD, Lee WM, et al. [A Case of a Korean Adult Affected by Type B Niemann-Pick Disease: Secondary Sea-blue Histiocytosis and Molecular Characterization.]. Korean J Lab Med. 2009 Apr. 29(2):97-103. [Medline].
Rodriguez-Pascau L, Gort L, Schuchman EH, Vilageliu L, Grinberg D, Chabas A. Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients. Hum Mutat. 2009 Mar 18. [Medline].
Simonaro CM, Desnick RJ, McGovern MM, Wasserstein MP, Schuchman EH. The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype/phenotype correlations. Am J Hum Genet. 2002 Dec. 71(6):1413-9. [Medline]. [Full Text].
Vykuntaraju KN, Lokanatha H, Shivananda. Niemann-Pick disease type A presenting as unilateral tremors. Indian Pediatr. 2012 Nov. 49(11):919-20. [Medline].
Wasserstein MP, Aron A, Brodie SE, Simonaro C, Desnick RJ, McGovern MM. Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease. J Pediatr. 2006 Oct. 149(4):554-9. [Medline].
Shah AJ, Kapoor N, Crooks GM, Parkman R, Weinberg KI, Wilson K, et al. Successful hematopoietic stem cell transplantation for Niemann-Pick disease type B. Pediatrics. 2005 Oct. 116(4):1022-5. [Medline].
McGovern MM, Lippa N, Bagiella E, Schuchman EH, Desnick RJ, Wasserstein MP. Morbidity and mortality in type B Niemann-Pick disease. Genet Med. 2013 Aug. 15(8):618-23. [Medline].